Merck & Co., Inc. (NYSE:MRK)

Here's the video pitch:

http://www.fool.com/investing/general/2012/02/02/the-5-year-outlook-for-this-dow-stock-merck.aspx

optimal chart pattern... breakout within a rising channel, on long term weekly charts.
not only has price broken out WITHIN the rising channel, but it's also closed a weekly candle with a higher high.

Would look to start entering on all oversold selloff reversals, intraday, particularly when seen above these levels.

Babo

Love the Dividend, and Long term Growth

Big insider buying in the summer, high yielder, plust this article in barrons.... http://online.barrons.com/article/SB50001424052748703893804577024954029429474.html?mod=BOL_article_full_popview

limit order placed on 11-9-11 when stock at 34.06

Is there really any words to say about this giant pharma ? I just bought some nice pile of stocks today , for the dividend , the defensivness and long term global growth prospects. If Merck is going down then be sure that the rest of the world is financially doomed also. One of my favorite pharma plays at a bargin price.

Multiple potential blockbusters in pipeline. Decent yield. Far safer than long-term bonds.

I work in a pharmacy their product sells. I don't care what kind of graph or chart you show me, because a good solid product will outperform.

I say outperform. I do so reluctantly. I do not have any weasel like choices. I am not at all convinced there is a pronouced direction. I have been selling off a small portion of my position for the last two years.

Long Term Outperform.

People looking for solid defensive moves with good dividend.

Just last week (8/11) had two insider buys on open market. CEO bought $1M and Exec VP&CFO bought $1/2M. They must think stock is a good buy aty almost 52 week low. Works for me.

Again, another macro play on big pharma, people need drugs, regardless of the economy... CFO/CEO buying on 52 week low... just dropped 2% out of the gate.. good time to pick it up.

Terrible leadership + atrocious decision making has fostered a culture of fear and indifference. Not sure how that bolsters the pipeline.

Yielding 4.82% Not even a dollar above it's 52 week low. Good deal.

If you are looking for a solid dividend company, MRK is your answer. This stock is finally undervalued with a P/E of about 9.3 and P/S of 6.0, two numbers that have recovered from a PE over 60. It has also shown growth with revenue growing 24.04%, a number that shows managable, not out of control sustainable recovery. The best part of Merck is the free cash, with way more than enough to cover their dividend, potentially increase the dividend, and add to the value of investors purchasing the stock since when you buy shares you are buying into the company and that cash essentially.

Merk has been outpaced by the S&P500 for over a decade. They are too large to outpace the market at this point, hence the rather tasty dividend they offer to keep investors interested. Easy pick for an under-perform long-term.

rotation into healthcare

At least 20 new drugs waiting last stage approval.